tiprankstipranks
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
US Market
CNTB
Connect Biopharma Holdings
RESEARCH TOOLSreports
Want to see CNTB full AI Analyst Report?

Connect Biopharma Holdings (CNTB) Stock News & Sentiment

151 Followers
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
Premium
Ratings
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
6d ago
CNTB
Connect Biopharma Advances Rademikibart After Positive Interim Review
Premium
Company Announcements
Connect Biopharma Advances Rademikibart After Positive Interim Review
25d ago
8K
CNTB
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
Premium
Ratings
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
2M ago
CNTB
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
Premium
Ratings
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
2M ago
CNTB
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
Premium
Company Announcements
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
2M ago
8K
CNTB
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CNTB
Connect Biopharma announces board resignation amid U.S. transition
Premium
Company Announcements
Connect Biopharma announces board resignation amid U.S. transition
5M ago
8K
CNTB
More CNTB News >

CNTB News on the Web

Connect Biopharma files to sell 6.13M ordinary shares for holders
TipRanks News
Neutral
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
TipRanks News
Bullish
Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright
TipRanks News
Bullish
Connect Biopharma reports Q1 EPS (34c), consensus (28c)
TipRanks News
Bullish
Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)
TipRanks News
Bullish
Connect Biopharma Advances Enrolment In Phase 2 Seabreeze STAT Trial For Asthma Drug Rademikibart
rttnews
Bullish
Connect Biopharma Advances Rademikibart After Positive Interim Review
TipRanks News
Neutral
Connect Biopharma announces enrollment in Seabreeze STAT study
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
CNTB
Sector Average
Media Buzz
This Week4 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CNTB’s Media Buzz Sentiment?
4 articles about CNTB were published this week. In an average week, 1 articles are published.
    What is CNTB’s weekly average amount of articles?
    In an average week, 1 articles about CNTB are published.
      What is CNTB’s News Sentiment?
      100% of articles about CNTB were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week